Aquestive Therapeutics, Inc. - 10-Q Filing

Aquestive Therapeutics reports Q3 2026 financial results and details ongoing debt obligations including senior secured notes.

SEC EDGAR ·

Tickers: $AQST

Read the full article at SEC EDGAR

More Regulatory news